Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

Colorectal cancer (CRC) organoids can be derived from almost all CRC patients and therefore capture the genetic diversity of this disease. We assembled a panel of CRC organoids carrying either wild-type or mutant RAS, as well as normal organoids and tumor organoids with a CRISPR-introduced oncogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Verissimo, Carla S, Overmeer, René M, Ponsioen, Bas, Drost, Jarno, Mertens, Sander, Verlaan-Klink, Ingrid, van Gerwen, Bastiaan, van der Ven, Marieke, van de Wetering, Marc, Egan, David A, Bernards, René, Clevers, Hans, Bos, Johannes L, Snippert, Hugo J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2016
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127645/
https://www.ncbi.nlm.nih.gov/pubmed/27845624
http://dx.doi.org/10.7554/eLife.18489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127645/
https://www.ncbi.nlm.nih.gov/pubmed/27845624
http://dx.doi.org/10.7554/eLife.18489

Ejemplares similares